Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress

2:30 PM - 3:45 PM, Tuesday, June 9, 2020 ・ Room 6A
Gene therapies are transforming patients’ lives in ways that were unimaginable twenty years ago. With recent scientific advances commercial gene therapies have been met with exciting opportunities for treatment for previously untreatable genetic diseases. With these advances come challenges and opportunities in scientific discovery and new approaches to developing and delivering genetic medicines. Gain insights and perspectives from stakeholders with experience tackling these challenges while bringing new types of treatments to patients. Find out what progress has been made since BIO 2019 and what is on the horizon for this exciting field.

Sponsored by Pfizer Inc.
Moderator
photo
Senior Vice President, Global Gene Therapy Business, Rare Disease, Global Innovation Pharma
Pfizer, Inc.
Speakers
Natalie Holles
President and Chief Executive Officer
Audentes, an Astellas Company
photo
Managing Director, Healthcare, Investment Baking
Morgan Stanley
Peter Marks
Director, Centers for Biologics Evaluation & Research
US Food & Drug Administration
photo
Chief Executive Officer & Founder
CureDuchenne